Search results
Biden admin seeks to delay releasing data on COVID vaccine reactions, report says
NBC Montana· 5 days agoThe Biden administration on Tuesday asked for a delay in releasing data on reactions to COVID-19 ...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 3 days agoEven if that target proves overly optimistic, much of the negative impact of the patent cliff could be offset by these new products and indications. ...
3 No-Brainer Stocks to Buy for Under $100 Right Now
The Motley Fool via AOL· 3 days agoEven if that target proves overly optimistic, much of the negative impact of the patent cliff could be offset by these new products and indications. Pfizer built a massive ...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation...
NewMediaWire via Yahoo Finance· 7 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...
3 No-Brainer Stocks to Buy for Under $100 Right Now | The Motley Fool
The Motley Fool· 3 days agoHere's why they picked AstraZeneca (AZN 0.41%), Bristol Myers Squibb (BMY 2.17%), and Pfizer (PFE)....
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 5 days agoThe Biden administration is seeking to delay until at least 2026 the release of COVID-19 vaccine...
New Pneumococcal Vaccine Approved
Medscape· 7 days agoThe new vaccine covers eight serotypes not protected by other vaccines already on the market.
Gateway - The Root
The Root· 6 days agoHealth experts in Mississippi and the federal level are urging residents in the state not to ingest ivermectin to treat COVID-19. In case you wanna know what ivermectin is, it is a drug designed ...
U.S. tariffs on Chinese goods demonstrate free trade myth
United Press International via Yahoo News· 7 days agoBy hiking tariffs on Chinese-made goods, the United States is once again trying to bend and change...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 7 days agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
